SCHEMBL6449059

SCHEMBL6449059

CC(C)[C@H](N)C(=O)N(C(=O)OCc1ccccn1)[C@@H](Cc1ccccc1)[C@H](O)[C@@H](O)[C@H](Cc1ccccc1)N(C(=O)OCc1ccccn1)C(=O)[C@@H](N)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
PTGS1 P23219 1/20 0.46
SLC6A2 P23975 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
MAOB P27338 1/20 0.42
CA2 P00918 2/20 0.41
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
ABCB1 P08183 1/20 0.38
SLC1A5 Q15758 1/20 0.38
SLC15A1 P46059 1/20 0.38
PTPRA P18433 1/20 0.38
GPR132 Q9UNW8 1/20 0.37
ACACB O00763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6445021 1.00 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6447678 1.00 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7275895 0.99 PGR (0.47) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7336658 0.89 PGR (0.41) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6449437 0.88 CA2 (0.44) CA2
SCHEMBL9741355 0.88 CA2 (0.44) CA2
SCHEMBL7278045 0.87 PGR (0.41) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7268623 0.86 PGR (0.40) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6448984 0.86 ABCB1 (0.43) MAOBLMNAABCB1SLC15A1POLB
SCHEMBL6454316 0.86 ABCB1 (0.43) MAOBLMNAABCB1SLC15A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP claimed
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP disclosed
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed